Tacchetti, Paola; Barbato, Simona; Mancuso, Katia; Zamagni, Elena; Cavo, Michele, Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma, «CANCERS», 2024, 16, Article number: 2337 , pp. 1 - 13 [Scientific article]Open Access
Pensato V.; Laginestra M.A.; Falvo P.; Orecchioni S.; Talarico G.; De Marchi E.; Bruno S.; Mongiorgi S.; Mitola G.; Bertolini F.; Adinolfi E.; Cavo M.; Curti A.; Salvestrini V., Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells, «STEM CELLS», 2024, 42, pp. 42 - 54 [Scientific article]Open Access
Vigliotta, Ilaria; Solli, Vincenza; Armuzzi, Silvia; Martello, Marina; Poletti, Andrea; Taurisano, Barbara; Pistis, Ignazia; Mazzocchetti, Gaia; Borsi, Enrica; Pantani, Lucia; Marzocchi, Giulia; Testoni, Nicoletta; Zamagni, Elena; Terracciano, Mario; Tononi, Paola; Garonzi, Marianna; Ferrarini, Alberto; Manaresi, Nicolò; Cavo, Michele; Terragna, Carolina, Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients, «CANCERS», 2024, 16, Article number: 2929 , pp. 1 - 22 [Scientific article]Open Access
Mancuso, K.; Mina, R.; Rocchi, S.; Antonioli, E.; Petrucci, M. T.; Fazio, F.; Gozzetti, A.; Salvini, M.; Cartia, C. S.; Bertuglia, G.; Patriarca, F.; Dalla Palma, A. B.; Barbato, S.; De Cicco, G.; Bigi, F.; Favero, E.; Tacchetti, P.; Pantani, L.; Rizzello, I.; Puppi, M.; Talarico, M.; Solli, V.; Kanapari, A.; Cavo, M.; Zamagni, E., Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study, «CANCER MEDICINE», 2024, 13, Article number: e70266 , pp. 1 - 12 [Scientific article]Open Access
Armuzzi, Silvia; Robustelli, Valentina; Taurisano, Barbara; Vigliotta, Ilaria; Martello, Marina; Pistis, Ignazia; Barone, Martina; Chirumbolo, Gabriella; Ciruolo, Raffaele; Cristiano, Gianluca; Sartor, Chiara; Curti, Antonio; Arpinati, Mario; Cavo, Michele; Papayannidis, Cristina; Terragna, Carolina, COMPARISON BETWEEN NGS IGH/TCR AND RT-PCR BCR::ABL1 MINIMAL RESIDUAL DISEASE IN PH+ ACUTE LYMPHOBLASTIC LEUKEMIA: A PRELIMINARY ANALYSIS, in: Haematologica 2024, 2024(atti di: 18th congresso sies, Firenze, 7-9 Marzo 2024) [Poster]
Sonneveld P.; Dimopoulos M.A.; Boccadoro M.; Quach H.; Ho P.J.; Beksac M.; Hulin C.; Antonioli E.; Leleu X.; Mangiacavalli S.; Perrot A.; Cavo M.; Belotti A.; Broijl A.; Gay F.; Mina R.; Nijhof I.S.; Van De Donk N.W.C.J.; Katodritou E.; Schjesvold F.; Sureda Balari A.; Rosiñol L.; Delforge M.; Roeloffzen W.; Silzle T.; Vangsted A.; Einsele H.; Spencer A.; Hajek R.; Jurczyszyn A.; Lonergan S.; Ahmadi T.; Liu Y.; Wang J.; Vieyra D.; Van Brummelen E.M.J.; Vanquickelberghe V.; Sitthi-Amorn A.; De Boer C.J.; Carson R.; Rodriguez-Otero P.; Bladé J.; Moreau P., Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2024, 390, pp. 301 - 313 [Scientific article]Open Access
Corradi, G.; Forte, D.; Cristiano, G.; Polimeno, A.; Ciciarello, M.; Salvestrini, V.; Bandini, L.; Robustelli, V.; Ottaviani, E.; Cavo, M.; Ocadlikova, D.; Curti, A., Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells, «FRONTIERS IN IMMUNOLOGY», 2024, 15, Article number: 1386517 , pp. 1 - 11 [Scientific article]Open Access
Sparano, F.; Giesinger, J. M.; Gaidano, G.; Anota, A.; Cavo, M.; Brini, A.; Voso, M. T.; Venditti, A.; Perrone, F.; Di Maio, M.; Luppi, M.; Baron, F.; Platzbecker, U.; Fazi, P.; Vignetti, M.; Efficace, F., Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System, «JCO ONCOLOGY PRACTICE», 2024, 20, pp. 438 - 447 [Scientific article]
Delforge M.; Patel K.; Eliason L.; Dhanda D.; Shi L.; Guo S.; Marshall T.S.; Arnulf B.; Cavo M.; Nooka A.; Manier S.; Callander N.; Giralt S.; Einsele H.; Ailawadhi S.; Popa McKiver M.; Cook M.; Rodriguez-Otero P., Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial, «THE LANCET. HAEMATOLOGY», 2024, 11, pp. 216 - 227 [Scientific article]
Martello, Marina; Solli, Vincenza; Mazzocchetti, Gaia; Solimando, Antonio Giovanni; Bezzi, Davide; Taurisano, Barbara; Kanapari, Ajsi; Poletti, Andrea; Borsi, Enrica; Armuzzi, Silvia; Vigliotta, Ilaria; Pistis, Ignazia; Desantis, Vanessa; Marzocchi, Giulia; Rizzello, Ilaria; Pantani, Lucia; Mancuso, Katia; Tacchetti, Paola; Testoni, Nicoletta; Nanni, Cristina; Zamagni, Elena; Cavo, Michele; Terragna, Carolina, High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis, «BLOOD CANCER JOURNAL», 2024, 14, Article number: 208 , pp. 1 - 10 [Scientific article]Open Access
Bigi F.; Manzato E.; Barbato S.; Talarico M.; Puppi M.; Masci S.; Sacchetti I.; Restuccia R.; Iezza M.; Rizzello I.; Sartor C.; Mancuso K.; Pantani L.; Tacchetti P.; Cavo M.; Zamagni E., Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review, «PHARMACEUTICALS», 2024, 17, Article number: 944 , pp. 7 - 7 [Scientific article]Open Access
Mateos, M. -V.; Engelhardt, M.; Leleu, X.; Mesa, M. G.; Cavo, M.; Dimopoulos, M.; Bianco, M.; Merlo, G. M.; Porte, C. L.; Richardson, P. G.; Moreau, P., Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2024, 113, pp. 242 - 252 [Scientific article]Open Access
Palandri F.; Palumbo G.A.; Benevolo G.; Iurlo A.; Elli E.M.; Abruzzese E.; Polverelli N.; Tiribelli M.; Auteri G.; Tieghi A.; Caocci G.; Binotto G.; Cavazzini F.; Branzanti F.; Beggiato E.; Miglino M.; Bosi C.; Crugnola M.; Bocchia M.; Martino B.; Pugliese N.; Scaffidi L.; Venturi M.; Duminuco A.; Isidori A.; Cattaneo D.; Krampera M.; Pane F.; Cilloni D.; Semenzato G.; Lemoli R.M.; Cuneo A.; Trawinska M.M.; Vianelli N.; Cavo M.; Bonifacio M.; Breccia M., Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy, «CANCER», 2024, 130, pp. 1270 - 1280 [Scientific article]Open Access
Bigi, F.; Tacchetti, P.; Giorgi, A.; Mazzocchetti, G.; Solli, V.; Barbato, S.; Sinigaglia, B.; Campanini, E.; Favero, E.; Talarico, M.; Puppi, M.; Rizzello, I.; Rocchi, S.; Mancuso, K.; Pantani, L.; Cavo, M.; Zamagni, E., Interference of daratumumab and efficacy of plerixafor on haematopoietic stem cell collection in Multiple Myeloma, «FRONTIERS IN HEMATOLOGY», 2024, 3, Article number: 1386973 , pp. 1 - 6 [Scientific article]Open Access
Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pérez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L, International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma, «THE LANCET ONCOLOGY», 2024, 25, pp. 0 - 0 [Scientific article]
